Neukio Biotherapeutics
PrivateLast Round
Series A
Sep 2, 2022
Total Funding Raised
$90M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neukio Biotherapeutics is a biotechnology company that develops iPSC-derived cell technology platforms and next-generation off-the-shelf immune cell products for treating solid tumors and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neukio Biotherapeutics Comparables
Compare Neukio Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CellOrigin Biotech | 89% | |
| Therabest | 88% | |
| Shoreline Biosciences | 84% |
Neukio Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 2, 2022 | ||||
| Angel | Jul 29, 2021 |
Neukio Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series A |
| IDG Capital | Angel, Series A |
| Lilly Asia Ventures | Series A, Angel |
| Sherpa Healthcare Partners | Series A |
| CD Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 68% MoM, reaching 2.4K.
- Apr 5, 2026
Monthly visitors increased 137% MoM.
Neukio Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neukio Biotherapeutics's valuation, stock price, and market status.
Is Neukio Biotherapeutics a public or private company?
Neukio Biotherapeutics is a private company.
What is the current stock price of Neukio Biotherapeutics?
Neukio Biotherapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Neukio Biotherapeutics worth (valuation)?
Valuation information for Neukio Biotherapeutics is not publicly available.
Can I buy Neukio Biotherapeutics stock?
Neukio Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neukio Biotherapeutics's last funding round?
Funding round information for Neukio Biotherapeutics is not publicly available.
Who are the main investors in Neukio Biotherapeutics?
Investor information for Neukio Biotherapeutics is not publicly disclosed.
Will Neukio Biotherapeutics IPO soon?
No public IPO plans have been announced for Neukio Biotherapeutics.
How can I track Neukio Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neukio Biotherapeutics's secondary market activity and sign up for updates.